Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;72(11):2061-2078.
doi: 10.1002/glia.24597. Epub 2024 Jul 26.

Astrocyte-TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke

Affiliations

Astrocyte-TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke

Cong Wang et al. Glia. 2024 Nov.

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) has been shown to confer strong neuroprotective effects in acute ischemic stroke (AIS). However, as the vast majority of research findings to date are based on its functions in microglia, the precise role of TREM2 in astrocytes after AIS is unknown. Here, both loss- and gain-of-function experiments were employed to investigate how astrocytic TREM2 influences the pathogenesis of AIS in vivo and in vitro. Our results demonstrated that cerebral ischemia triggered induction of TREM2 expression on reactive astrocytes following AIS. In addition, astrocyte-specific TREM2 knockout mice exhibited much greater brain injury than TREM2 flox/flox controls following AIS, as evidenced by increased cerebral infarct volume, neuronal apoptosis and neurological deficit, which was associated with an increased expression of pro-inflammatory molecule complement component 3 (C3) on reactive astrocytes and activation of microglia/macrophages but decreased expression of S100 calcium binding protein A10 (S100A10) and arginase1 (Arg1) on reactive astrocytes. Mechanistic analyses revealed that astrocytic TREM2 alleviated brain injury by inhibiting detrimental actions of reactive astrocytes but promoting their neuro- and glioprotective actions via the kruppel-like transcription factor-4-nuclear factor-κB axis. Together, this study provides novel evidence for a critical protective role of astrocyte-derived TREM2 in AIS and highlights a potential therapeutic target for the treatment of AIS.

Keywords: astrocyte activation; cerebral ischemic stroke; neuroinflammation; neuroprotection; triggering receptor expressed on myeloid cells 2.

PubMed Disclaimer

References

REFERENCES

    1. Aguiar de Sousa, D., von Martial, R., Abilleira, S., Gattringer, T., Kobayashi, A., Gallofré, M., Fazekas, F., Szikora, I., Feigin, V., Caso, V., & Fischer, U. (2019). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal, 4(1), 13–28.
    1. Alhadidi, Q. M., Xu, L., Sun, X., Althobaiti, Y. S., Almalki, A., Alsaab, H. O., & Stary, C. M. (2022). MiR‐182 inhibition protects against experimental stroke in vivo and mitigates astrocyte injury and inflammation in vitro via modulation of cortactin activity. Neurochemical Research, 47(12), 3682–3696.
    1. Alsbrook, D. L., Di Napoli, M., Bhatia, K., Biller, J., Andalib, S., Hinduja, A., Rodrigues, R., Rodriguez, M., Sabbagh, S. Y., Selim, M., Farahabadi, M. H., Jafarli, A., & Divani, A. A. (2023). Neuroinflammation in acute ischemic and hemorrhagic stroke. Current Neurology and Neuroscience Reports, 23(8), 407–431.
    1. Amantea, D., Micieli, G., Tassorelli, C., Cuartero, M. I., Ballesteros, I., Certo, M., Moro, M. A., Lizasoain, I., & Bagetta, G. (2015). Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Frontiers in Neuroscience, 9, 147.
    1. Belayev, L., Hong, S. H., Freitas, R. S., Menghani, H., Marcell, S. J., Khoutorova, L., Mukherjee, P. K., Reid, M. M., Oria, R. B., & Bazan, N. G. (2020). DHA modulates MANF and TREM2 abundance, enhances neurogenesis, reduces infarct size, and improves neurological function after experimental ischemic stroke. CNS Neuroscience & Therapeutics, 26(11), 1155–1167.